Novel Peptide Found to Kill Breast Cancer, Leave Healthy Tissue Unharmed

Novel Peptide Found to Kill Breast Cancer, Leave Healthy Tissue Unharmed
A newly found peptide that can kill tumor cells while sparing healthy cells could be an effective therapeutic strategy, when combined with other drugs, for drug-resistant cancers such as breast cancer, according to the study, “Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy," published in the latest edition of the journal Oncotarget. Peptide Therapeutics for Breast Cancer According to the research literature and the National Institutes of Health (NIH), peptide therapeutics are considered  promising for the advancement of breast cancer drug target development. Peptides are part of the building blocks of protein structure and consist of one or two bonded amino acids in a chain. The structural templates of the building blocks can be manipulated in the laboratory to develop peptides that play a therapeutic role in fighting disease such as breast cancer. Challenges in the field of peptide therapeutics include improving delivery modalities that specifically target a patient’s tumor —  and understanding the potential safety and toxicity risks associated with the novel treatment. About this Study Researchers  from the A*STAR Bioprocessing Technology Institute, in Singapore,  found that a segment of the hexamethylen
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.